Stephany P Monsanto1, Andrew K Edwards1, Juhua Zhou2, Prakash Nagarkatti2, Mitzi Nagarkatti2, Steven L Young3, Bruce A Lessey4, Chandrakant Tayade5. 1. Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. 2. Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina. 3. Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina. 4. Department of Obstetrics and Gynecology, Greenville Health Systems, Greenville, South Carolina. 5. Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. Electronic address: tayadec@queensu.ca.
Abstract
OBJECTIVE: To determine the impact of endometriotic lesion removal on local and systemic inflammation. DESIGN: Multiplex cytokine analysis on samples from endometriosis patients before surgery, 2 weeks after surgery, and 3 months after surgery. SETTING: Academic teaching hospital and university. PATIENT(S): A total of 43 endometriosis patients before and after excision of lesions by means of laparoscopic surgery, and 25 normal women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Plasma, eutopic and ectopic tissue, and peritoneal fluid cytokine levels. RESULT(S): Compared with presurgery plasma samples, levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL) 2, IL-8, and IL-10 decreased significantly by 2 weeks after surgery in endometriosis patients. Interestingly, levels began to rise at 3 months after surgery in most cases. In tissue, levels of GM-CSF and IL-15 were lower in eutopic tissue, while levels of basic fibroblast growth factor, interferon-inducible protein 10, IL-1 receptor antagonist, granulocyte colony-stimulating factor, macrophage inflammatory protein 1β, IL-7, and IL-5 were higher in eutopic than in ectopic tissue. In peritoneal fluid, levels of IL-5 and IL-12 were higher in early versus advanced stages of endometriosis. Compared with normal women, plasma from endometriosis patients had higher levels of inflammatory cytokines. CONCLUSION(S): Endometriotic lesion removal significantly alters the inflammatory profile both locally and systemically in women with endometriosis. Our findings indicate that ectopic lesions are the major drivers of systemic inflammation in endometriosis. The transitory nature of the change may reflect the recurrence of the condition and the influence of systemic factors in its onset.
OBJECTIVE: To determine the impact of endometriotic lesion removal on local and systemic inflammation. DESIGN: Multiplex cytokine analysis on samples from endometriosispatients before surgery, 2 weeks after surgery, and 3 months after surgery. SETTING: Academic teaching hospital and university. PATIENT(S): A total of 43 endometriosispatients before and after excision of lesions by means of laparoscopic surgery, and 25 normal women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Plasma, eutopic and ectopic tissue, and peritoneal fluid cytokine levels. RESULT(S): Compared with presurgery plasma samples, levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL) 2, IL-8, and IL-10 decreased significantly by 2 weeks after surgery in endometriosispatients. Interestingly, levels began to rise at 3 months after surgery in most cases. In tissue, levels of GM-CSF and IL-15 were lower in eutopic tissue, while levels of basic fibroblast growth factor, interferon-inducible protein 10, IL-1 receptor antagonist, granulocyte colony-stimulating factor, macrophage inflammatory protein 1β, IL-7, and IL-5 were higher in eutopic than in ectopic tissue. In peritoneal fluid, levels of IL-5 and IL-12 were higher in early versus advanced stages of endometriosis. Compared with normal women, plasma from endometriosispatients had higher levels of inflammatory cytokines. CONCLUSION(S): Endometriotic lesion removal significantly alters the inflammatory profile both locally and systemically in women with endometriosis. Our findings indicate that ectopic lesions are the major drivers of systemic inflammation in endometriosis. The transitory nature of the change may reflect the recurrence of the condition and the influence of systemic factors in its onset.
Authors: Kasra Khalaj; Jessica E Miller; Harshavardhan Lingegowda; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade Journal: JCI Insight Date: 2019-09-19
Authors: Niraj R Joshi; Eduardo H Miyadahira; Yalda Afshar; Jae-Wook Jeong; Steven L Young; Bruce A Lessey; Paulo C Serafini; Asgerally T Fazleabas Journal: J Clin Endocrinol Metab Date: 2017-01-01 Impact factor: 5.958
Authors: Jessica E Miller; Stephany P Monsanto; Soo Hyun Ahn; Kasra Khalaj; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade Journal: Sci Rep Date: 2017-12-20 Impact factor: 4.379
Authors: Susan F Evans; Yuen H Kwok; Ann Solterbeck; Jiajun Liu; Mark R Hutchinson; M Louise Hull; Paul E Rolan Journal: J Pain Res Date: 2020-03-09 Impact factor: 3.133
Authors: Jung-Yoon Yoo; Jae-Wook Jeong; Asgerally T Fazleabas; Chandrakant Tayade; Steven L Young; Bruce A Lessey Journal: Biol Reprod Date: 2016-05-25 Impact factor: 4.285